<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
SCYX
Scynexis
$
()


  • Scynexis price target lowered by $1 at Guggenheim, here's why

    4/2/2024 - 07:02am
  • Scynexis reports FY23 EPS $1.39, consensus $1.42

    3/28/2024 - 16:08pm
  • Scynexis announces presentation of data from fungerp candidate SCY-247

    1/29/2024 - 17:23pm
  • Scynexis to present preclinical data on SCY-247

    1/5/2024 - 08:31am
  • Scynexis reports binding MOU with GSK for amendment to license agreement

    1/3/2024 - 08:46am
  • Scynexis reports Q3 EPS (4c), consensus (15c)

    11/13/2023 - 17:22pm
  • Scynexis files $200M mixed securities shelf

    11/13/2023 - 17:12pm
  • Scynexis files to sell 32.52M shares of common stock

    11/13/2023 - 16:49pm
  • Scynexis presents new preclinical data on SCY-247

    10/24/2023 - 08:08am
  • Scynexis issues voluntary nationwide recall of BREXAFEMME

    9/27/2023 - 20:53pm
  • What You Missed On Wall Street On Monday

    9/25/2023 - 16:27pm
  • Scynexis down 29% after announcing Brexafemme recall

    9/25/2023 - 09:04am
  • Scynexis recalling Brexafemme from market, placing temporary hold on studies

    9/25/2023 - 09:03am
  • Scynexis trading resumes

    9/25/2023 - 09:00am
  • Scynexis trading halted, news pending

    9/25/2023 - 08:25am
dynamic_feed Breaking News